COGNIDEP 5 TABLET contains Donepezil which belongs to the group of medicines called Cholinesterase inhibitors. COGNIDEP 5 TABLET is indicated for the management of mild to moderately severe Alzheimer’s dementia.
Alzheimer's disease is a brain disorder that causes dementia (a group of symptoms that affect the memory, thinking and social abilities of a person) by destroying the memory and other important mental functions in the brain which is characterized by memory loss, confusion, and behavioral changes.
Before taking COGNIDEP 5 TABLET, inform your doctor if you are allergic to Donepezil, have asthma, heart, kidney, or liver disease.
COGNIDEP 5 TABLET is not recommended for use if you have severe liver disease. Consult your doctor before taking medicine.
COGNIDEP 5 TABLET is generally not recommended for use in pregnant and breastfeeding women unless it is considered clearly necessary. Consult your doctor before taking COGNIDEP 5 TABLET.
The safety and effectiveness of COGNIDEP 5 TABLET in pediatric patients have not been established.
The most common side effects of taking COGNIDEP 5 TABLET are diarrhoea, feeling sick, tiredness, difficulty in sleeping, common cold, loss of appetite, hallucinations, and aggressive behaviour. Consult your doctor if any of these above side effects get worse.
No content available
